These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39342122)

  • 1. Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer.
    Wu Z; Xiang H; Wang X; Zhang R; Guo Y; Qu L; Zhou J; Xiao Y
    Mol Med; 2024 Sep; 30(1):166. PubMed ID: 39342122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
    J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis.
    Zhang Y; Wei S; Zhang Q; Zhang Y; Sun C
    Phytomedicine; 2024 Jul; 130():155746. PubMed ID: 38763012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of Huachansu Injection against colorectal cancer based on network pharmacology and cellular experimental].
    Meng ZY; Zhao J; Zhu QF; Xiang DF; Meng JJ; Chen JJ; Jiang B; Hu YJ; Xu LY; Zhang XQ; Zou H; Han YL
    Zhongguo Zhong Yao Za Zhi; 2024 Sep; 49(17):4755-4767. PubMed ID: 39307810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of action of 1,4-naphthoquinone scaffold-derived compounds against acute myeloid leukemia based on network pharmacology, molecular docking and molecular dynamics simulation.
    Chen R; Liu H; Meng W; Sun J
    Sci Rep; 2024 Sep; 14(1):21043. PubMed ID: 39251712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology.
    Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
    Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
    Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
    Zhao M; Fu L; Xu P; Wang T; Li P
    Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses.
    Wang D; Xie D; Meng S; Mi J; Wang H; Li L; Zhang Y; Cui Y
    BMC Cancer; 2024 Sep; 24(1):1217. PubMed ID: 39350059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer.
    Yang X; Li F; Shi Y; Wu Y; Yang R; Liu X; Zhang Y; Zhang G; Ma M; Luo Z; Han X; Xie Y; Liu S
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):763-775. PubMed ID: 38516703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Emodin in the Treatment of Bladder Cancer Based on Network Pharmacology and Experimental Verification.
    Liu F; Li J; Zhou B; Shen Y; Tang J; Han J; Chen C; Shao K; Chen H; Yuan L
    Comb Chem High Throughput Screen; 2024; 27(11):1661-1675. PubMed ID: 38504574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin inhibits proliferation and differentiation of cardiac fibroblasts through AKT/GSK3β signaling pathway.
    Kan H; Wang P; Yang Y; Jia H; Liu A; Wang M; Ouyang C; Yang X
    J Ethnopharmacol; 2024 Nov; 334():118518. PubMed ID: 38964628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
    Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
    Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.
    Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
    Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the Molecular Mechanisms of Resveratrol in Treating Cardiometabolic Multimorbidity: A Network Pharmacology and Bioinformatics Approach with Molecular Docking Validation.
    Gong W; Sun P; Li X; Wang X; Zhang X; Cui H; Yang J
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Mechanism of Yishan Formula in Treating Breast Cancer Based on Network Pharmacology and Experimental Verification.
    Lin X; Chi W; Geng X; Jiang Q; Ma B; Dai B; Sui Y; Jiang J
    Comb Chem High Throughput Screen; 2024; 27(17):2583-2597. PubMed ID: 38178684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer.
    Yuan X; Huang H; Yu C; Tang Z; Li Y
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6507-6521. PubMed ID: 38446216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach.
    Li X; Yu D; Wang Q; Chen Y; Jiang H
    Chem Biol Interact; 2024 Jun; 396():111058. PubMed ID: 38761877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.